HEMISPHERX BIOPHARMA INC.

Company

AIM ImmunoTech Inc.

Filed

January 27, 1998

Accession Number

0000950128-98-000378

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →